Summit recap and photos!
View this email in your browser
November 2014 Issue

Note from the President

2014 Utah Life Science Summit Sets Record for Registration, Sponsorship


Summit also marks the culmination of original COO Peter Knauer’s tenure on the BioUtah leadership team.   


The fifth annual Utah Life Science Summit established new standards for both the number of registrants and the level of sponsorship support.    


More than 380 individuals registered for Utah’s premier life science event, while Summit-specific sponsorships reached a total of $73,000.


BioUtah would like to pay tribute to the sponsors who helped make this year’s event such an extraordinary success:

  • Our $15,000 Gold Sponsors for the event were Intermountain Healthcare and Crocker Ventures/The Sorenson Legacy Foundation. The Intermountain team at the Summit was led by George Hamilton, VP of Business Development and Vice Chair of the BioUtah Board of Directors. Crocker Ventures/Sorenson Legacy Foundation was represented by top Utah serial entrepreneur and investor Gary Crocker.   

  • Our $10,000 Silver Sponsor was Lefavi Wealth Management, led at the Summit by Bruce Lefavi, noted financial expert and long-time radio show host

  • There were four Bronze Sponsors at $5,000 each: Biomerics, represented by CEO and BioUtah Board member Travis Sessions; Richard J. Linder, CEO and founder of CoNextions Medical and Chair of the BioUtah Board of Directors; Lineagen, led by CEO Michael Paul; and VWR, led by Western States representative Chuck Ebert.

  • Three $2,500 Contributor Sponsors for the Summit included AdvaMed’s Emerging Growth Company Council (EGCC), led by EGCC executive director Ashley Wallin; Myriad Genetics, represented by Chief Commercial Officer and BioUtah Board member Alexander (Alec) Ford; Stryker, led by Mark Paul, President of the Neurovascular Division and Summit keynote speaker;

  • In addition, three generous sponsors provided support for BioUtah’s new STEM Student Scholarship Awards program for high school students focused on Science, Technology, Engineering and Math. A contribution of $2,500 was received from Edwards Lifesciences, and a $1,500 table sponsorship was received from the Utah STEM Action Center, BioUtah’s official partner in the STEM Awards and the Utah Governor’s Office of Economic Development, represented by Kevin Jessing, Life Science Cluster Director.

  • These awards enabled two scholarship recipients and eight additional students to attend the Utah Life Science Awards with their parents and teachers. All winners and finalists received special recognition from BioUtah and U.S Congressman Jim Matheson at the Utah Life Science Awards.     


The 2014 Utah Life Science Summit set a high bar for coming years, but the BioUtah team is committed to rising to the occasion, on behalf of our members and partners.


Next year, we look forward to again saying, “See you at the Summit!”   


On a personal note, the BioUtah team wishes the very best for one of our original team members, Peter Knauer. The Utah Life Science Summit marked Peter's last day as COO of BioUtah. Peter played a key role in helping establish BioUtah on a sound foundation. Peter and other key members of the former Intermountain Biomedical Association (IBA) have been instrumental in creating a robust regulatory/compliance presence for BioUtah and the life science community we serve. We are grateful Peter will continue to actively participate with BioUtah, though we will miss our daily interactions with him as a member of the core team!


All the best,

Kimball Thomson

President & CEO


BioUtah Institute


Photo Highlights of the 2014 Utah Life Science Summit


Mark Paul, President of Stryker Neurovascular, provides the Summit’s first keynote, focusing on Utah’s potential as a global life science epicenter. Paul leads successful teams that sell medical devices in 60 countries.  

The Summit’s second keynote was provided by Mark Reisman, MD, Clinical Professor of Medicine, Section Head for Interventional Cardiology and Director of Cardiovascular Emerging Therapies at University of Washington Medical Center. Reisman is also head of several cardiology programs nationally, and has been the principal investigator on more than 50 clinical trials to date.

Ted Stanley, MD, renowned anesthesiologist, entrepreneur, investor and inventor of the fentanyl citrate lollipop, received the 2014 Willem J. Kolff Lifetime Achievement Award (left), from BioUtah CEO Kimball Thomson and 2013 Kolff Award winner Dinesh Patel, PhD. 

Peter Knauer (left), outgoing COO of BioUtah and the BioUtah Institute, receives a special recognition award from Susannah Hutchins (middle), BioUtah’s Director of Administration & Special Projects, and BioUtah CEO Kimball Thomson.

Suzanne Winters, PhD, recipient of the 2014 BioUtah Outstanding Individual Contribution Award, which recognizes "persistent heroism, integrity and commitment to excellence at work and in the community." With Congressman Jim Matheson, BioUtah chairman Rich Linder and CEO Kimball Thomson.

Tamara Goetz, PhD, executive director of the Utah STEM Action Center and assistant dean for External Relations at Utah Valley University, receiving the Outstanding Public Service Award, for "unfailing commitment to improving the business, legislative and regulatory climate for Utah’s life science community."  Presented by Congressman Jim Matheson, BioUtah chairman Rich Linder and CEO Kimball Thomson.

The 2014 BioUtah Outstanding Company Service Award, for "extraordinary achievement and impact on Utah's life science community by an organization," was presented to BioFire Diagnostics. CEO Randy Rasmussen accepted the award from Jim Matheson, BioUtah chairman Rich Linder and CEO Kimball Thomson. 

In addition to the core Utah Life Science Awards, BioUtah honored outgoing Congressman Jim Matheson for his exemplary service to Utah's life science community during his highly productive 14-year tenure in the U.S. Congress.

Additional photos are available HERE.

White Paper:

How Effective Training Management Can Help You Prevent Quality Issues

“Training is what helps turn the theory of quality into reality,” said Dave Hunter, product management director at MasterControl. Yet, for most companies in the regulated environment, quality is a concept manifested largely in paper instead of training through policies, SOPs, work instructions, manuals, and other materials. 
It’s not enough to have your quality standards on paper. You have to implement and integrate them into your daily operations and prove to regulators that your standards and policies work. “Effective training should be a fundamental part of a company’s quality management strategy as it can help prevent many quality problems from ever occurring,” said Hunter.
In a regulated environment, training is a means to minimize (if not avoid) human error, a common cause of deviations and nonconformances. It’s no wonder that various standards and regulations, such as the following, require training as an integral part of the quality management system.
               â–ªâ–ª FDA 21 CFR Part 211.25 for pharmaceutical companies
               â–ªâ–ª FDA 21 CFR Part 820.25 for medical device manufacturers
               â–ªâ–ª ISO 9000 2000 for general manufacturers and other businesses
               â–ªâ–ª ISO 13485 for medical device manufacturers 


Special Notice



Utah Life Science News

Recursion Pharmaceuticals Announces Robert Lollini as the Second Member of Business Advisory Panel
Recursion Pharmaceuticals, a biotech start-up in Salt Lake City, announced the appointment of Robert Lollini, MBA, CPA, to its business advisory panel.Mr. Lollini is a distinguished leader in the life sciences, having served as President and Chief Executive Officer of IOMED, Inc. and Myrexis, Inc.Currently Mr. Lollini serves as the Chief Financial Officer of BioFire Diagnostics, a clinical diagnostics company recently acquired by the multinational biotechnology company BioMerieux (see also Recursion Pharmaceuticals, LLC).

 Jade Therapeutics, Inc., announced today the election of Randall Olson, M.D., Chief Executive Officer and Chair of the Department of Ophthalmology and Visual Sciences of the John A. Moran Eye Center at the University of Utah School of Medicine, to a newly created position on the Company's Board of Directors.

When Intermountain Healthcare, a large Utah-based hospital system, invested in digital health accelerator Healthbox last April, they announced that Intermountain would be one of the first testbeds for a...

Program in Personalized Health Care
Foundations in Personalized Health Care [MDCRC6150] Course and CME

Course Description

Foundations in Personalized Health Care is a survey course designed to introduce students to many facets of this emerging field. This course will review the fundamental elements of personalized health care, discuss relevant case studies of preventive and therapeutic applications of personalized health care, and explore future developments. Students will also have the opportunity to devise ways in which personalized health care can be advanced locally, nationally and globally. Sponsored by the University of Utah Program in Personalized Health Care and the Center for Clinical and Translational Science (CCTS), the course is offered through the Master of Science in Clinical Investigation (MSCI) program. This course is open to students outside the MSCI program and can be approved as an elective in other degree programs. A Continuing Education section also is available. Faculty, staff and the public are welcome to attend the seminar portion of the course.

Download and post a course flyer



Entrepreneur friendly, no cap, no discount, convertible note.
Entrepreneur friendly, no cap, no discount, convertible note.
Entrepreneur friendly, no cap, no discount, convertible note.

National Life Science News

Majority of top Android and iOS apps have been hacked
According to a recent report by mobile security firm Arxan Technology, the overwhelming majority of top paid and free apps for both iOS and Android have been hacked. And that prevalence of hacking extends to FDA-cleared health apps as well.

Study: Medical device industry facing $34 billion revenue hit
The confluence of five forces could create a $34 billion hit to the medical device industry's revenues over the next five years.
Until now, the medical device industry has enjoyed stability, strong growth, healthy margins and above average price-to-earnings ratios over the last 20 years. But disruptive changes are causing industry executives to focus on differentiated sources of value, customer productivity and total patient disease management, said Dave Powell, a partner with A.T. Kearney and a co-author of a study that delves into the industry's challenges.


How much does it cost to get a drug approved? A new estimate puts the number at $2.55 billion, more than twice the cost assessed by the same lead researcher a decade ago. Not everyone believes the math.

The techie term “net neutrality” likely isn't in the daily lexicon used by most senior healthcare executives. But it should be, and soon, argue those in healthcare technology who have been following the topic.

Bulletin Board

  • When
    02 Dec 2014
    3:00 PM - 6:00 PM
  • Location
    Zions Bank 1 South Main Street, 18th Floor - Founders Room Salt Lake City, UT 84133

This Deal Forum is a live pitch event and will feature a number of entrepreneurs who are seeking capital for their ventures. This event is designed specifically to provide a safe venue where entrepreneurs can pitch their ventures to a panel of investors for the sole purpose of receiving feedback on their venture, pitch content, as well as market opportunity assumptions, forecasts, or necessary milestones needed to become successful.  

We are pleased to announce our new partnership with the Life Science industry’s most well-regarded and prestigious professional development practitioners –
Life CollaborativeBuilding Healthy Careers in Life Sciences.

Life Collaborative offers a suite of eLearning resources to help prepare you for a career, or advance the one you’ve already got, in the Life Science industry. The Life Collaborative curriculum was created and validated by real-world industry practitioners and, to that end, is backed by a Certificate of Achievement. Life Collaborative topics include - BioTech, MedTech, Pharmaceuticals, Project Management, Quality, Regulatory, Sales & Marketing, Finance, Team Leadership, and more.

Members Receive as much as a 45% Discount

To get started in your e-learning program, please select from one of the options below:

Professional programs are designed for individuals who are currently employed full time in a Life Science organization and are not seeking employment.

Student / Job Seeker programs are designed for individuals who are interested in transitioning into a Life Science company.

Note that the Life Collaborative has partnered with the MedTech and BioTech Veterans Program ( to provide scholarships to transitioning veterans. If you, or your company, are interested in learning more about MVPvets, email


If you have questions about which program to select, or would like to learn about the Life Collaborative corporate licensing program, or custom learning management options, please email or call 760-444-9460.

Copyright © 2014 BioUtah, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp